Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure

American Journal of Nephrology

Volumn 23, Issue 5, 2003, Pages 315-323

  Ataka, Ken ^a   Maruyama, Hiroki ^a   Neichi, Tomohiro ^b   Miyazaki, Jun Ichi ^c   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Anemia associated with chronic renal failure; Gene therapy; In vivo electroporation; Muscle targeted gene transfer; Plasmid

Indexed keywords

ADENINE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY WEIGHT; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPORATION; GENE TRANSFER; HEMATOCRIT; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN; TREATMENT OUTCOME; UREMIA;

ADENINE; ANEMIA; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ELECTROPORATION; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOCRIT; HINDLIMB; INJECTIONS, INTRAMUSCULAR; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; PLATELET COUNT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UREMIA;

EID: 0141681012     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072913     Document Type: Article

References (24)

1. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990;248:378-381.
2. Hamamori Y, Samal B, Tian J, Kedes L: Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest 1995;95:1808-1813.
3. Svensson EC, Black HB, Dugger DL et al: Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997;8:1797-1806.
4. Osborne WRA, Ramesh N, Lau S, Clowes MM, Dale DC, Clowers AW: Gene therapy for long-term expression of erythropoietin in rats. Proc Natl Acad Sci USA 1995;92:8055-8058.
5. Kessler PD, Podsakoff GM, Chen X et al: Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996;93:14082-14087.
6. Tripathy SK, Svensson EC, Black HB et al: Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci USA 1996;93:10876-10880.
7. Aihara H, Miyazaki J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998;16:867-870.
8. Maruyama H, Sugawa M, Moriguchi Y et al: Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Hum Gene Ther 2000;11:429-437.
9. Maruyama H, Ataka K, Gejyo F et al: Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther 2001;8:461-468.
10. Rizzuto G, Cappelletti M, Mennuni C et al: Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000;11:1891-1900.
11. Yokozawa T, Zheng PD, Oura H, Koizumi F: Animal model of adenine-induced chronic renal failure in rats. Nephron 1986;44:230-234.
12. Okada H, Kaneko Y, Yawata T et al: Reversibility of adenine-induced renal failure in rats. Clin Exp Nephrol 1999;3:82-88.
13. Valderrabano F: Erythropoietin in chronic renal failure. Kidney Int 1996;50:1373-1391.
14. Lacasse MS, Kingma I, Lariviere R, Grose JH, Lebel M: Uremia enhances the blood pressure response to erythropoietin. Clin Exp Hypertens 1997;19:389-401.
15. Escbach JW, Adamson JW: Anemia of end-stage renal disease. Kidney Int 1985;28:1-5.
16. NKF-K/DOQI: Clinical practice guidelines for anemia of chronic kidney disease: Update 2000. Am J Kidney Dis 2001;37:S182-S240.
17. Poux JM, Lartigue M, Chaisemartin RA, Galen FX, Leroux-Robert C: Uraemia is necessary for erythropoietin-induced hypertension in rats. Clin Exp Pharmacol Physiol 1995;22:769-771.
18. Roth D, Smith RD, Schulman G et al: Effects of recombinant human erythropoietin on renal function in chronic renal failure in predialysis patients. Am J Kidney Dis 1994;24:777-784.
19. Markham A, Bryson HM: Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 1995;49:232-254.
20. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-199.
21. Ohwada K: Improvement of cardiac puncture in mice (in Japanese). Exp Anim 1986;35:353-355.
22. Kuwahara M, Sugano S, Yayou K et al: Evaluation of a new tail-cuff method for blood pressure measurement in rats with special reference to the effects of ambient temperature. Exp Anim 1991;40:331-336.
23. McDonald TP, Clift R, Cottrell MB: Large, chronic doses of erythropoietin cause thrombocytopenia in mice. Blood 1992;80:352-358.
24. Osada S, Ebihara I, Setoguchi Y, Takahshi H, Tomino Y, Koide H: Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene. Kidney Int 1999;55:1234-1240.